Product Number |
OAAF02355 |
Product Page |
www.avivasysbio.com/pfkp-antibody-oaaf02355.html |
Name |
PFKP Antibody (OAAF02355) |
Molecular Weight |
85 kDa |
NCBI Gene Id |
5214 |
Host |
Rabbit |
Clonality |
Polyclonal |
Gene Full Name |
phosphofructokinase, platelet |
Alias Symbols |
6-phosphofructokinase type C;6-phosphofructokinase, platelet type;ATP-dependent 6-phosphofructokinase, platelet type;ATP-PFK;PFK-C;PFKF;PFK-P;phosphofructo-1-kinase isozyme C;phosphofructokinase 1;phosphohexokinase. |
Product Format |
Liquid |
Reference |
Eto K., Biochem. Biophys. Res. Commun. 198:990-998(1994). Simpson C.J., Biochem. Biophys. Res. Commun. 180:197-203(1991). Beausoleil S.A., Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). |
Description of Target |
Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis. |
Reconstitution and Storage |
-20°C |
Datasheets/Manuals |
Printable datasheet for PFKP Antibody (OAAF02355) |
Specificity |
K6PP antibody detects endogenous levels of total K6PP protein. |
Application Info |
WB: 1:500~1:3000; ELISA: 1:1000 |
Immunogen |
The antiserum was produced against synthesized peptide derived from human K6PP. |
Dilution |
The optimal working dilution should be determined by the end user. |
Formulation |
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Uniprot ID |
Q01813 |
Protein Name |
ATP-dependent 6-phosphofructokinase, platelet type |
Protein Accession # |
NP_002618.1 |
Purification |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Gene Symbol |
PFKP |
Predicted Species Reactivity |
Human|Monkey|Mouse|Rat |
Application |
Enzyme-linked immunosorbent assay|Immunocytochemistry|Immunofluorescence|Immunohistochemistry|Immunohistochemistry-Paraffin|Western blot |
Image 1 | A549/COS7 cells
| Western blot analysis of extracts from A549/COS7 cells, using K6PP Antibody. The lane on the right is treated with the synthesized peptide. |
|
|